The global market for Human Vaccines was valued at US$46.9 Billion in 2024 and is projected to reach US$71.4 Billion by 2030, growing at a CAGR of 7.3% from 2024 to 2030. This comprehensive report ...

Hegseth Conscripts the Pentagon for Trump’s “Retribution Campaign” (Noah Robertson, Tara Copp and Sarah Ellison, Washington Post) In threatening to deploy the military justice system against Democrats ...

Researchers say in future it may be possible to grow personalized organoids from patient’s own tissue, to test potential treatments in advance.

Disease development is often shaped by genetics, with how much or how little a gene is expressed influencing disease risk.

The beauty of the DNA code is that organisms interpret it unambiguously. Each three-letter nucleotide sequence, or codon, in a gene codes for a unique ...

A peculiar black fungus discovered in Chernobyl's reactor ruins exhibits an astonishing ability to survive and potentially thrive on extreme radiation ...

Discusses Strategic Partnership to Transform Engineering and Design Through AI and Accelerated Computing December 1, 2025 10:00 ...

On Monday, she will be inducted into a special sisterhood, Polytechnique Montréal’s Order of the White Rose, which offers a ...

Najat Khan, PhD, unpacks realistic timelines for AI-based drugs to make clinical impact and her priorities for Recursion as incoming CEO.

TSRA-196 is a potential one-time treatment to precisely correct the genetic mutation underlying AATD, with Investigational New Drug filing expected by the end of the year Tessera to receive $150 ...

A new FDA pathway could speed bespoke gene therapies, but key questions over scope and commercial viability remain.